In an effort to widen supply and improve access to its weight loss drug Zepbound for people who do not have insurance, Eli Lilly & Co. has introduced a new version of the medication at half the price. The drug is now available in 2.5 mg and 5 mg single-dose vials through the manufacturer’s direct-to-consumer website, costing $399 and $549 per month, respectively.
Full Story: CNBC (8/27)